BeStock  
Stocks › Biotechnology › PBLS

Parabilis Medicines PBLS

US equityMarket cap rank #2333Biotechnology
$27.44 −$0.19 (-0.67%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $27.44 0.00%
Open$27.07
Prev close$27.63
Day range$26.50 – $28.52
Volume1.25M
Market cap$3.44B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-15.1x
CheapRich

Above its usual level · 75th percentile, 5-year average -16.8x

Price / book3.5x
CheapRich

Above its usual level · 68th percentile, 5-year average -0.4x

#3982 of 5330 stocks by PB (1 = cheapest)

Price / sales24,061.4x
CheapRich

Above its usual level · 62nd percentile, 5-year average 15,611.9x

#5149 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-24x-15x-7x2xJun '26Aug '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$34.19
Price vs. fair value-19.7%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.55 – -0.40 68% (pricier than usual) #3982 of 5330 (1 = cheapest)
PE -15.14 -18.36 -16.79 75% (pricier than usual) –
PS 24,061.35 736.78 15,611.86 62% (pricier than usual) #5149 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PBLS.

Sign in to join the discussion.

Scroll to Top